October 18, 2013
The Federal Circuit on Friday denied Eli Lilly and Co.'s appeal to stop the transfer of its patent suit against Genentech Inc. from the Northern to the Southern District of California, holding that Eli Lilly had not shown the transfer was a clear abuse of discretion.